Skip to content

Effects of Milk Powder Intervention on Body Composition and Physical Performance in Middle-aged and Older Adults

Effects of Daily Supplementation With Milk Powder on Body Composition and Physical Performance in Middle-aged and Older Adults: A Randomized Control Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06429410
Enrollment
200
Registered
2024-05-28
Start date
2024-05-31
Completion date
2026-07-31
Last updated
2024-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

This study aims to conduct a 24-week intervention involving formula milk powder for middle-aged and elderly individuals, assessing its impact on body composition and physical performance in comparison to interventions using regular milk powder and individuals without intervention.

Interventions

DIETARY_SUPPLEMENTfortified formula milk powder

Fortified formula milk powder supplemented with whey protein, calcium, vitamin D, colostrum basic protein, β-hydroxy-β-methylbutyrate, and sodium hyaluronate per day orally for 24 weeks.

DIETARY_SUPPLEMENTformula milk powder

Formula milk powder supplemented with whey protein, calcium, vitamin D, colostrum basic protein, and sodium hyaluronate per day orally for 24 weeks.

DIETARY_SUPPLEMENTregular milk powder

Regular milk powder does not contain and additional supplementation, and the color, flavor, shape, taste, and weight are same with the formula milk powder.

Sponsors

Huilian Zhu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 50 years old and older; * BMI \<22kg/m2; * Calf circumference \<33cm in women or \<34cm in men, or SARC-F ≥ 4, or SARC-Claf ≥ 11; * Living in Guangzhou and having no plan to move in the next 6 months; * Willing to participate in the study.

Exclusion criteria

* Lactose intolerance; * Complicated with severe diseases; * Unable to conduct study procedures; * Participating in any other intervention studies.

Design outcomes

Primary

MeasureTime frameDescription
lean body massup to 24 weeksAt baseline, and 24 weeks, investigators will use DXA to examine lean body mass and fat composition.

Secondary

MeasureTime frameDescription
cardiorespiratory fitnessup to 24 weeksAt baseline, and 24 weeks, investigators will use cardiopulmonary exercise testing (CPET) on a cycle ergometer to evaluate cardiorespiratory fitness.
muscle strengthup to 24 weeksAt baseline, 12, and 24 weeks, investigators will test hand grip to assess muscle strength.
physical performanceup to 24 weeksAt baseline, 12, and 24 weeks, investigators will test the Short Physical Performance Battery (SPPB) to assess muscular function.
the levels of blood metabolic markers for bone and muscleup to 24 weeksAt baseline, and 24 weeks, blood samples will be drawn and serum indexes of bone and muscle metabolism will be test, including myostatin, PINP, CTx, and osteocalcin.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026